Hiromatsu Y, Sato M, Inoue Y, Koga M, Miyake I, Kameo J, Tokisawa S, Yang D, Nonaka K
Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan.
Thyroid. 1996 Dec;6(6):553-62. doi: 10.1089/thy.1996.6.553.
We have studied the cellular localization of thyrotropin receptor (TSH-R) mRNA in orbital fat and extraocular muscle tissues from patients with thyroid-associated ophthalmopathy (TAO) using Northern blot, reverse transcriptase polymerase chain reaction (RT-PCR), and in situ hybridization, and we correlated the findings with clinical estimates of ophthalmopathy. Although we failed to detect TSH-R mRNA in orbital tissues by Northern blot, TSH-R cDNA was amplified in orbital fat tissue from 13 of 25 patients with TAO and from 2 of 4 control subjects, in eye muscle tissue from 2 out of 7 patients with TAO, and in cultured orbital fibroblasts and subcutaneous fibroblasts from TAO patients. In situ hybridization showed that TSH-R mRNA was detected in cultured orbital fibroblasts as well as skin fibroblasts obtained from the patient. Furthermore, the expression of TSH-R mRNA in orbital fat tissue from patients with TAO significantly correlated with the orbital fat volume and the severity of ophthalmopathy, especially the extent of eye muscle dysfunction. These results suggest that the expression of TSH-R in the orbit, especially fibroblasts, may play a role in the pathogenesis and clinical manifestations of the ophthalmopathy in patients with TAO, although a secondary effect, involving fibroblasts in TAO is also possible.
我们运用Northern印迹法、逆转录聚合酶链反应(RT-PCR)和原位杂交技术,研究了促甲状腺激素受体(TSH-R)mRNA在甲状腺相关眼病(TAO)患者眼眶脂肪和眼外肌组织中的细胞定位,并将研究结果与眼病的临床评估进行了关联分析。尽管我们通过Northern印迹法未能在眼眶组织中检测到TSH-R mRNA,但在25例TAO患者中的13例以及4例对照受试者中的2例的眼眶脂肪组织中,在7例TAO患者中的2例的眼肌组织中,以及在TAO患者的培养眼眶成纤维细胞和皮下成纤维细胞中,TSH-R cDNA均得到了扩增。原位杂交显示,在培养的眼眶成纤维细胞以及从患者获取的皮肤成纤维细胞中均检测到了TSH-R mRNA。此外,TAO患者眼眶脂肪组织中TSH-R mRNA的表达与眼眶脂肪体积以及眼病的严重程度显著相关,尤其是眼肌功能障碍的程度。这些结果表明,眼眶中TSH-R的表达,尤其是成纤维细胞中的表达,可能在TAO患者眼病的发病机制和临床表现中起作用,尽管也可能存在涉及TAO中成纤维细胞的继发性效应。